ArticleNanoscale advances2025
Crystallization of neomycin nanoparticles in the presence of polyvinyl pyrrolidone (PVP).
Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neomycin nanoparticles were prepared using the inductive crystallization method in the presence of polyvinylpyrrolidone (PVP) as a stabilizer. Given the favorable solubility of neomycin in water, distilled water was used as the solvent. In addition, acetone was utilized as the antisolvent due to its high polarity and good solubility in water. The produced neomycin nanoparticles were characterized by various analyses such as TEM, HR-TEM, SEM, FE-SEM, FT-IR, XRD, DSC, TGA, AFM, DLS, and EDX. The DLS analysis indicated a bimodal size distribution from 17 to 235 nm. The induction time and nucleation mechanism were also determined. The results showed that the primary nucleation mechanism was the prevailing process, as validated by the higher
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.